Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

By D. Lyden, K. Hattori, S. Dias, Carla Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. Marks, L. Witte and 10 more. Nature Medicine, 2001

1,994 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/3243e1a9d0f47792bafe48408965e44a84d69f82

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. J. Joyce
2. Zena Werb
3. N. Ferrara
4. H. Gerber
5. M. Egeblad
6. E. Nakasone
7. D. McDonald
8. L. Matrisian

In Molecular Biology

1. J. Joyce
2. Zena Werb
3. N. Ferrara
4. E. Nakasone
5. M. Egeblad
6. H. Gerber
7. Shahin Rafii
8. D. McDonald

In Oncology

1. J. Joyce
2. Zena Werb
3. M. Egeblad
4. E. Nakasone
5. N. Ferrara
6. L. Matrisian
7. D. McDonald
8. H. Gerber

Citations in the corpus

• Preparing the "soil": the premetastatic niche. (2006, background): “interfering with the chemotactic response and diminishing perivascular investment (18).”
• Tumor angiogenesis and vascular normalization: alternative therapeutic targets (2017, background): “Multiple studies have been published in the last fifteen years describing the involvement of endothelial precursor cells (EPC) in tumor angiogenesis [68, 69].”